Published in Drug Week, May 5th, 2000
"Somavert holds tremendous promise as a new treatment option for patients with acromegaly," said endocrinologist and co-author Anne Klibanski, MD, Massachusetts General Hospital and Harvard Medical School. "This new therapy significantly improved the clinical signs and symptoms...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.